arrow_back Trending Legislation
Share share

Preventing Illegal Laboratories and Protecting Public Health Act of 2026

This act establishes strict tracking for dangerous pathogens and increases oversight of high-security laboratories. It aims to protect public health by ensuring that hazardous biological agents are only sold to verified individuals for legitimate purposes.
Key points
Mandatory electronic logbooks for the sale, lease, or transfer of highly dangerous pathogens.
Requirement for identity verification and detailed descriptions of the purchaser's intended use and storage location.
Criminal penalties for providing false information when acquiring hazardous biological agents.
Establishment of national safety standards and strategic evaluations for high-containment laboratories.
Creation of a federal biosafety support team to assist state and local agencies with security concerns.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Preventing Illegal Laboratories and Protecting Public Health Act of 2026
Print number: S 4227
Sponsor: Sen. Cortez Masto, Catherine [D-NV]
Process start date: 2026-03-26
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Preventing Illegal Laboratories and Protecting Public Health Act of 2026

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 4227.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2026-03-26.

What are the main provisions?

Key points include:

  • Mandatory electronic logbooks for the sale, lease, or transfer of highly dangerous pathogens.
  • Requirement for identity verification and detailed descriptions of the purchaser's intended use and storage location.
  • Criminal penalties for providing false information when acquiring hazardous biological agents.
  • Establishment of national safety standards and strategic evaluations for high-containment laboratories.
  • Creation of a federal biosafety support team to assist state and local agencies with security concerns.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cortez Masto, Catherine [D-NV].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-04-13.

Analysis and Potential Impact of S 4227

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Security